X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GBIO

Closed

Generation Bio co

0.32
0.00 (0.00%)
Last Update: 01 Jul 2025 23:16:00
Yesterday: 0.3201
Day's Range: 0.3111 - 0.3361
Send
When Written:
 
4.11
Generation Bio Co is a biotechnology company that focuses on developing gene therapies for the treatment of genetic diseases. The company was founded in 2016 and is headquartered in Cambridge, Massachusetts. Generation Bio's platform technology is designed to enable the development of gene therapies that can be delivered using a single intravenous infusion, which could potentially offer a more convenient and cost-effective approach to treating genetic diseases. The company's lead product candidate is a gene therapy for the treatment of phenylketonuria (PKU), a rare genetic disorder that affects the body's ability to process an amino acid called phenylalanine. Generation Bio has partnerships with several pharmaceutical companies, including Biogen and Novartis, to develop gene therapies for a range of genetic diseases.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X